This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Deutsche Diabetes-Forschungsgesellschaft E.v.—trager Des Deutschen Diabetes-Zentrums Dusseldorf, Eberhard Karls Universitat Tubingen Medizinische F Akultat, Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 5 
1 out of 94 
Years Active: 2017
Title: H-Erich Wichmann: Innovator in Diabetes Research
Introduction
H-Erich Wichmann is a notable inventor based in Neuherberg, Germany. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes mellitus. His work has the potential to impact the way diabetes is diagnosed and treated.
Latest Patents
H-Erich Wichmann holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This method involves assessing specific metabolites in a sample obtained from a subject. The invention focuses on two groups of metabolites, where changes in their levels can indicate a predisposition to diabetes. Additionally, the patent includes methods for identifying compounds that can prevent diabetes and selecting appropriate therapies.
Career Highlights
Throughout his career, Wichmann has worked with prominent research institutions. He has been associated with the Helmholtz Zentrum München, which is known for its research in health and environmental sciences. He has also contributed to the Deutsche Diabetes-Forschungsgesellschaft, which is a key player in diabetes research in Germany.
Collaborations
Wichmann has collaborated with notable colleagues in his field, including Wolfgang Rathmann and Christian Herder. Their combined expertise has furthered research efforts in diabetes and related health issues.
Conclusion
H-Erich Wichmann's innovative work in identifying biomarkers for type 2 diabetes represents a significant advancement in medical research. His contributions have the potential to improve diabetes prevention and treatment strategies.